Corner cutting compromises clinical trials: the inherent problems with up-front randomisation and a common standard arm. by Hills, R, Richards, S, Wheatley, K

Higher daunorubicin exposure benefits FLT3 mutated acute myeloid leukemia by Burnett, A, Russell, N, Hills, R

The prognostic significance of trisomy 4 in acute myeloid leukaemia is dependent on age and additional abnormalities by Chilton, L, Hills, R, Burnett, A, Harrison, C

Implementation of an optimized Cassegrain system for radio telescopes by Holler, C, Hills, R, Jones, M, Grainge, K, Kaneko, T

SpySwitch enables pH- or heat-responsive capture and release for plug-and-display nanoassembly by Vester, S, Rahikainen, R, Khairil Anuar, I, Hills, R, Tan, T, Howarth, MR

FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute... by Mead, A, Linch, D, Hills, R, Wheatley, K, Burnett, A, Gale, R

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study. by Gray, R, Barnwell, J, McConkey, C, Hills, R, Williams, N, Kerr, D

Conflicting data on the prognostic significance of FLT3/TKD mutations in acute myeloid leukemia might be related to the incidence of biallelic disease. by Mead, A, Gale, R, Hills, R, Gupta, M, Young, B, Burnett, A, Linch, D

CIP2A- and SETBP1-mediated PP2A inhibition reveals AKT S473 phosphorylation to be a new biomarker in AML by Lucas, C, Scott, L, Carmell, N, Holcroft, A, Hills, R, Burnett, A, Clark, R

The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia... by Gale, R, Green, C, Allen, C, Mead, A, Burnett, A, Hills, R, Linch, D

Attenuated arsenic trioxide plus ATRA therapy for newly diagnosed and relapsed APL: Long-term follow-up of the AML17 trial by Russell, N, Burnett, A, Hills, R, Betteridge, S, Dennis, M, Jovanovic, J, Dillon, R, Grimwade, D

QUASAR: A randomized study of adjuvant chemotherapy (CT) vs observation including 3238 colorectal cancer patients. by Gray, R, Barnwell, J, Hills, R, McConkey, C, Williams, N, Kerr, D, Grp, Q

Increased frequency of CD4+PD‐1+HLA‐DR+ T cells is associated with disease progression in CLL by Elston, L, Fegan, C, Hills, R, Hashimdeen, SS, Walsby, E, Henley, P, Pepper, C, Man, S

Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. by Tomlinson, J, Holden, N, Hills, R, Wheatley, K, Clayton, R, Bates, A, Sheppard, M, Stewart, P

Outcomes of relapsed/refractory patients with IDH1/2 mutated AML treated with non-targeted therapy: results from the NCRI AML trials by Hills, R, Gale, R, Linch, D, Huntly, B, Papaemmanuil, E, Vyas, P, Burnett, A, Russell, N

QUASAR Collaborative Group: a randomised study of adjuvant chemotherapy (CT) vs observation in predominantly stage II colorectal cancer by Kerr, D, Barnwell, J, Hills, R, McConkey, C, Williams, N, Quirke, P, Grumett, S, Gray, R

Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials by Gray, R, Hills, R, Stowe, R, Clarke, M, Peto, R, Buyse, M, Piedbois, P, Grp, C

PROSPER: a randomised comparison of surgical treatments for rectal prolapse. by Senapati, A, Gray, R, Middleton, L, Harding, J, Hills, R, Armitage, N, Buckley, L, Northover, J

Assessing the prognostic value of preoperative carcinoembryonic antigen-specific T-cell responses in colorectal cancer by Scurr, M, Brown, C, Bento, D, Betts, G, Rees, B, Hills, R, Gallimore, A, Godkin, A

Evaluation of prognostic models developed using standardised image features from different PET automated segmentation methods by Parkinson, C, Foley, K, Whybra, P, Hills, R, Roberts, A, Marshall, C, Staffurth, J, Spezi, E